Session Details

Poster Oral Presentation 10

Fri. Jul 11, 2025 1:00 PM - 1:45 PM JST
Fri. Jul 11, 2025 4:00 AM - 4:45 AM UTC
Room Ⅶ (Makuhari Messe International Conference Room)(Makuhari Messe International Conference Room) 10

[PO-090]Multi-ethnic Asian Inflammatory Bowel Disease Multi-omic Study (ILETIS) - Study Protocol and Pilot Findings

*Claire Shiying Tan1, Lin Liu2, Bernice Wenyu Tan1, John Shao Rong Mok1, Shu Kuan Pang1, Shi Min Sim2, Xiaodan Cai2, Shanni Chen2, Stephen Kwa2, Juanda Leo Hartono1, Jonathan Wei Jie Lee1,2,3 (1. Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, 2. Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 3. iHealthtech, National University of Singapore, Singapore)
Comment()

[PO-091]Psychosine confines Th1 and Th17 cell proliferation and immune responses in inflammatory bowel diseases

*Ritian Lin1, Lan Zhong1 (1. Department of Gastroenterology, Shanghai East Hospital, Tongji University of School Medicine, Shanghai, China)
Comment()

[PO-092]From Fibroblast Heterogeneity to Pro-Fibroblast Crosstalk: A Single-Cell Atlas of Crohn’s Disease-Associated Anorectal Stricture

*Yuanyuan Ge1, Kang Ding1 (1. Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine)
Comment()

[PO-093]Investigating the Role of Ubiquitination in the Pathogenesis of Crohn's Disease: Insights from Single-Cell Analysis

*Mengqi Luo1, Yufang Wang1 (1. Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China.)
Comment()

[PO-094]Immune Signatures of Mesalazine Intolerance in Patients with Ulcerative Colitis using RNA Sequencing of CD4+ T Cells.

*Takashi Taida1, Yuki Ohta1, Ryo Nakagawa1, Kento Shimizu1, Yoshiki Matsubara1, Takuya Ohashi1, Toshiyuki Ito1, Nobuaki Shu1, Yusuke Ozeki1, Makoto Furuya1, Ryosuke Horio1, Chihiro Goto1, Akane Kurosugi1, Tatsuya Kaneko1, Kenichiro Okimoto1, Keiko Saito1, Tomoaki Matsumura1, Jun Kato1 (1. Chiba University)
Comment()

[PO-095]Qingchang Suppository Promotes Mucosal Healing in Ulcerative Colitis Through the TGF-β/Th9-PU.1/IL-9 Signaling Pathway: From Clinical to Cellular Scenarios

*Juntao Lu1, Jingyi Shan2 (1. Renji Hospital, Shanghai Jiaotong University, School of Medicine, 2. Longhua Hospital, Shanghai University of Traditional Chinese Medicine)
Comment()

[PO-096]Qingchang Suppository Promotes Intestinal Mucosal Repair in Ulcerative Colitis by Inhibiting TGF-b/Th9-PU.1/IL-9 Signaling Pathway

*Jingyi Shan1, Junren Yao1, Yuchen Liu1, Jing Ni1, Juntao Lu2, Jiang Lin1 (1. Longhua Hospital, Shanghai University of Traditional Chinese Medicine, 2. Renji Hospital, Shanghai Jiaotong University, School of Medicine)
Comment()

[PO-097]ADAMDEC1+ EREG+ FIBROBLAST DRIVES THE PERSISTENCE OF CHRONIC INFLAMMATION VIA INTERACTIONS WITH IL1RN+MACROPHAGE IN CROHN'S DISEASE

*Zhi Yin Feng1, Jin Shen He1, Jing Nie1, Jia Xin Wang2, Jie Li1, Yao Zhang2, Long Yuan Zhou1, Ren Mao1 (1. The First Affiliated Hospital, Sun Yat-Sen University, 2. Ruijin Hospital, Shanghai Jiaotong University School Of Medicine)
Comment()

[PO-098]PCDH20 regulates pro-inflammatory Th1 cells in Crohn's disease

*Shanshan Huang1 (1. Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University)
Comment()

[PO-099]The Role of Malic Enzyme 1 in Macrophage Pyroptosis and Inflammatory Bowel Disease Progression

*Huan Zhang1, Jie Feng1, Qinpei Zhang1, Qinhua Xi1 (1. First Affiliated Hospital of Soochow University.)
Comment()

[PO-100]BMPR2-F456Y Mutation Causes Hirschsprung Disease via Protein Destabilization and SMAD Signaling Impairment

*Yong Li1, Duo Xu1, Shengdi Zhang1, Yu Peng1, Yu Wu1 (1. Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China)
Comment()